The case points to several changes in the way data are collected and released that are urgently needed to determine definitively whether SSRI’s are safe and effective for treating pediatric depression. Tighter regulation of all clinical trials is needed, as is a public worldwide database that contains trial protocols and regularly updated information about trial status and publications.